PDA

View Full Version : pfe

Pages : [1] 2 3 4 5 6 7
  1. Ypsilanti efforts win major parts of Pfizer community grant
  2. Pfizer CEO: Best to back parts of health reform
  3. Pfizer, PlaNet Finance Partner to Study Options for Expanding Access to Healthcare in
  4. Pfizer CEO Says Alzheimer's Advance Would Be Proudest Legacy
  5. Pfizer’s Oncology Business Unit Appoints Senior Executive to Head US Region
  6. StandoutStocks.com: "Stocks that Standout" picks for today are: ATPG, ITWO, PFE, UAUA
  7. Most Of ERISA Securities Case V. Pfizer Moves Ahead
  8. BRIEF: State seeks $225 million from Pfizer for overcharges
  9. BRIEF: State seeks $225 million from Pfizer for overcharges
  10. Elan Corporation PLC (NYSE:ELN) - Operating performance to return to profitability fr
  11. State seeks $225 million after jury finds overcharges: Van Hollen suggests $100 to $2
  12. Allergan May Join Sector Takeover Waves (AGN, GSK, DNA, PFE, WYE, MRK, SGP)
  13. FABLYN ® Approved in Europe for the Treatment of Osteoporosis
  14. Pfizer, Pharmacia Stock-Drop Case Moves Forward
  15. Pfizer, Ligand Osteoporosis Drug Approved in Europe
  16. NEWS | SAN DIEGO Ligand receives payment on European drug approval
  17. NEWS | SAN DIEGO Ligand receives payment on European drug approval
  18. Pfizer, PlaNet to research healthcare for working poor in China
  19. Myriad Genetics, Pfizer, Novo Nordisk lead gainers
  20. Pfizer closes $13.5 billion notes offering
  21. NEWS | SAN DIEGO Ligand receives payment on European drug approval
  22. NEWS | SAN DIEGO Ligand receives payment on European drug approval
  23. The FDA Leaves Pfizer in the Waiting Room
  24. Energy execs: Don't look for more Suncor-sized deals
  25. Life Sciences Entrepreneur
  26. Pfizer Completes $13.5 Billion Note Offering
  27. Pfizer closes USD13.5bn debt offering
  28. Promising Stocks in the Bargain Bin: Pfizer
  29. March 22-28 is Cover the Uninsured Week
  30. Vista, Others Drop Claims In Neurontin Case V. Pfizer
  31. Vista, Others Drop Claims In Neurontin Case V. Pfizer
  32. Wyeth laying off 13 in Pearl River
  33. Pfizer's Oncology Business Unit Taps Elizabeth Barrett to Head US Region
  34. Wyeth’s Poussot Gets $51 Million Package After Sale to Pfizer
  35. Wyeth’s Poussot Gets $24.3 Million on Termination
  36. Wyeth’s Poussot Gets $24.3 Million on Termination
  37. Soybean process yields Pfizer's top Michigan product
  38. Soybean process yields Pfizer's top Michigan product
  39. Ligand Pharmaceuticals and Pfizer Get EC Approval for Fablyn
  40. Ligand Pharmaceuticals and Pfizer Get EC Approval for Fablyn
  41. News > Unternehmensnachrichten > Pfizer Invites Public to View and Listen to ...
  42. Pfizer Invites Public to View and Listen to Webcast of April 28 Conference Call with
  43. Pfizer Invites Public to View and Listen to Webcast of April 28 Conference Call with
  44. Wyeth CEO to Get $53 million Under Pfizer Deal
  45. Wyeth CEO to Get $53 million Under Pfizer Deal
  46. PennyPerformers.com: "Penny Stocks that Perform" picks are: ARNA, CYPB, GTCB, PFE, PG
  47. Pfizer says Lipitor 80 mg reduce relative risk of first cardiovascular event by 23% i
  48. Abbott Labs (ABT) Held Preliminary Talks With Wyeth (WYE) Before Pfizer Deal
  49. Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
  50. Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
  51. Pfizer Invites Public to View and Listen to Webcast of April 28 Conference Call with
  52. Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
  53. Pfizer Aims To Rely On More Diverse Product Line
  54. Significantly More Patients With Cardiovascular Disease Quit Smoking Using Chantix/Ch
  55. Eli Lilly CEO Says Another Acquisition To Come
  56. Pfizer Said to End Rezulin Claims at $205 Million Under Reserve
  57. SemBioSys provides update on insulin program
  58. SemBioSys provides update on insulin program
  59. Uses of Pfizer site mulled
  60. Pfizer near $75 mln settlement with Nigeria-sources
  61. Pfizer near $75 mln settlement with Nigeria-sources
  62. Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Adva
  63. Pfizer Stops One Sutent Advanced Breast Cancer Study
  64. Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas
  65. Stock Alerts For: AEP, AUY, PFE, SIRI, RIO, and F released by MonsterPennyStocks.com
  66. Pfizer's pipeline shrinks with research changes
  67. Pfizer's pipeline shrinks with research changes
  68. Stock Alerts For: AEP, AUY, PFE, SIRI, RIO, and F released by MonsterPennyStocks.com
  69. Pfizer moves arthritis, pain drugs to late trials
  70. RPT-STOCKS NEWS US-Barclays downgrades Amazon to equal-weight
  71. Stock Alerts For: AEP, AUY, PFE, SIRI, RIO, and F released by MonsterPennyStocks.com
  72. Attack Of The Zombie Biotechs
  73. Nigera, Pfizer settlement 'close'
  74. AM Best Upgrades Ratings of Blue Whale Re Ltd.
  75. AM Best Upgrades Ratings of Blue Whale Re Ltd.
  76. Abbott Labs A Solid Pharma Stock (ABT, PFE, MRK, GSK, AZN)
  77. Pfizer Becomes The First Pharmaceutical Company To Be Accredited For Protection Of Hu
  78. Neurontin Class Action V. Pfizer Dismissed
  79. Pfizer Receives Request for Additional Information from FTC Regarding Proposed Acquis
  80. Bristol-Myers sale? No, says analyst, reversing course
  81. FTC Requests More Info From Pfizer Over Wyeth Aquisition
  82. FTC Requests More Info From Pfizer Over Wyeth Aquisition
  83. FTC Requests More Info From Pfizer Over Wyeth Aquisition
  84. The growth potion
  85. SUCCESSFUL INVESTING with Andrew Leckey
  86. Foreign pharmaceutical giants Pfizer, Abbot report lower profits
  87. Pfizer Updates Development Pipeline
  88. Pfizer Receives Request...
  89. Pfizer Receives Request...
  90. Pfizer Becomes The First Pharmaceutical Company To Be Accredited For Protection Of Hu
  91. Pfizer Receives Request for Additional Information from FTC Regarding Proposed Acquis
  92. Aggressive Investors Convert Blue Chips to Penny Stocks in a Depressed Economy
  93. Aggressive Investors Convert Blue Chips to Penny Stocks in a Depressed Economy
  94. Pfizer Kept at a Hold
  95. Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity
  96. Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity
  97. Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity
  98. Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas
  99. Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity
  100. Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas
  101. Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity
  102. Pfizer Becomes The First Pharmaceutical Company To Be Accredited For Protection Of Hu
  103. Zacks Analyst Blog Highlights: Pfizer Inc., Wyeth, Satyam Computer Services Ltd., Abb
  104. Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity
  105. Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity
  106. Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effecti
  107. Pfizer Outlines R&D Leadership, Integrating Wyeth Researchers
  108. Pfizer unveils organization structure and leadership plan for post-Wyeth merger - Upd
  109. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  110. Research pitfalls in Pfizer-Wyeth integration?
  111. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  112. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  113. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  114. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  115. StandoutStocks.com: "Stocks that Standout" picks for today are: EPIX, LIFE, MDRX, PFE
  116. Zacks Analyst Blog Highlights: Pfizer Inc., Wyeth, Satyam Computer Services Ltd., Abb
  117. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  118. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  119. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  120. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  121. MOTLEY FOOL Pfizer has a new hit
  122. Pfizer has a new hit
  123. MOTLEY FOOL Pfizer has a new hit
  124. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  125. Pfizer Planning to Have Two Research Chiefs Upon Wyeth Acquisition
  126. Kennedy Wilson Auction Group Awarded Commercial Brokerage Assignment
  127. Wyeth Offers Limited Upside
  128. FACTBOX- Biggest changes in NYSE short interest
  129. Wyeth Offers Limited Upside
  130. Pfizer’s Oncology Business Unit Appoints Vice President of Medical Affairs
  131. NEWS | SAN DIEGO Pfizer names new VP of oncology
  132. NEWS | SAN DIEGO Pfizer names new VP of oncology
  133. NEWS | SAN DIEGO Pfizer names new VP of oncology
  134. NEWS | SAN DIEGO Pfizer names new VP of oncology
  135. NEWS | SAN DIEGO Pfizer names new VP of oncology
  136. NEWS | SAN DIEGO Pfizer names new VP of oncology
  137. NEWS | SAN DIEGO Pfizer names new VP of oncology
  138. Pfizer Global Manufacturing, a Subsidiary of Pfizer Inc., Terre Haute, IN; Notice of
  139. NEWS | SAN DIEGO Pfizer names new VP of oncology
  140. Pfizer auctioning massive Portage office building
  141. Pfizer scores with cancer drug
  142. Lobbying on Taxes Paid Off for Pfizer, HP, Kansas Study Says
  143. NEWS | SAN DIEGO Pfizer names new VP of oncology
  144. Lobbying on Taxes Paid Off for Pfizer, HP, Kansas Study Says
  145. NEWS | SAN DIEGO Pfizer names new VP of oncology
  146. Pfizer To Make A Tender Offer To Increase Stake In Pfizer Limited
  147. Pfizer To Make A Tender Offer To Increase Stake In Pfizer Limited
  148. Pfizer offers to boost stake in Indian arm
  149. Pfizer offers to boost stake in Indian arm
  150. NEWS | SAN DIEGO Pfizer names new VP of oncology
  151. Pfizer gets a hit!
  152. NEWS | SAN DIEGO Pfizer names new VP of oncology
  153. Pfizer Inc's Oncology business unit names VP of Medical Affairs
  154. SmarTrend® News Watch: Pfizer Increases India Unit Holding
  155. SmarTrend® News Watch: Pfizer Increases India Unit Holding
  156. SmarTrend® News Watch: Pfizer Increases India Unit Holding
  157. Pfizer Increases India Unit Holding
  158. The Fairholme Fund Continues To Thrive (PFE, SHLD, FRX, CNQ)
  159. Listerine is good for J&J -- and aspiring governors?
  160. Great Call on Pfizer! What's Next?
  161. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patient
  162. StandoutStocks.com: "Stocks that Standout" picks for today are: DIIG, NBL, PFE, SKYW,
  163. StandoutStocks.com: "Stocks that Standout" picks for today are: DIIG, NBL, PFE, SKYW,
  164. Big Pharma Sees Value In Using Small Drug Discovery Units
  165. Big Pharma Sees Value In Using Small Drug Discovery Units
  166. Pfizer names Alaix to lead animal health
  167. LIC dissents at Pfizer AGM over MD’s salary
  168. LIC dissents at Pfizer AGM over MD’s salary
  169. GlaxoSmithKline, Pfizer to Combine HIV Businesses
  170. GlaxoSmithKline, Pfizer to Combine HIV Businesses
  171. Stock Alerts for AMZN, BP, PFE, DIS, and JBLU Released by Seven Summits Research
  172. Options Edge: Nucor Corp., Southwest Airlines, Dendreon Corp., and Pfizer Inc.
  173. Options Edge: Nucor Corp., Southwest Airlines, Dendreon Corp., and Pfizer Inc.
  174. Pfizer open offer for India unit to start June 10
  175. Pfizer open offer for India unit to start June 10
  176. GlaxoSmithKline and Pfizer to Create New HIV Company
  177. FIs object to Pfizer’s open offer for arm
  178. Overall Pfizer Regional Impact Is 3,000 Jobs And Over $400 Million Annually
  179. Stocks to watch: Unitech, Jet Airways, Suzlon, Bhushan Steel, Pfizer, Tata Comm, PFC
  180. Zacks Analyst Blog Highlights: Infinity Pharmaceuticals Inc, Novartis, Pfizer, OmniVi
  181. Zacks Analyst Blog Highlights: Infinity Pharmaceuticals Inc, Novartis, Pfizer, OmniVi
  182. Pfizer Merger Hangs Wyeth Investors Out To Dry: Suit
  183. Zacks Analyst Blog Highlights: Infinity Pharmaceuticals Inc, Novartis, Pfizer, OmniVi
  184. Pfizer helps form statewide group to promote industry
  185. Summary Box: Pfizer still big in Michigan
  186. Pfizer names oncology VP
  187. Kalamazoo study finds Pfizer factory release drug
  188. Kalamazoo study finds Pfizer factory release drug
  189. Pfizer among companies polluting US water supplies
  190. Pfizer names oncology VP
  191. Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders
  192. Kalamazoo study finds Pfizer factory release drug
  193. Kalamazoo study finds Pfizer factory release drug
  194. Kalamazoo study finds Pfizer factory release drug
  195. Kalamazoo study finds Pfizer factory release drug
  196. Kalamazoo study finds Pfizer factory release drug
  197. Kalamazoo study finds Pfizer factory release drug
  198. Kalamazoo study finds Pfizer factory release drug
  199. Pfizer dedicates newly renovated building in downtown Kalamazoo
  200. Unusual Option Activity on Merck (MRK), Pfizer (PFE), and Broadcom (BRCM) - www.ONN.t
  201. Pfizer and Medicines for Malaria Venture Advancing International Research Efforts in
  202. HotStockProfiles.com Releases Trade Alerts On Market Movers Today: F, PFE, T, SGP, FC
  203. HotStockProfiles.com Releases Trade Alerts On Market Movers Today: F, PFE, T, SGP, FC
  204. Big Pharma 'evergreening' nixed
  205. Pfizer and Glaxo Join Forces in HIV Venture
  206. Innovative partnership aims to reduce cardiovascular disease in Nova Scotia
  207. Pfizer Hosts Annual Meeting Of Shareholders; Declares A 16-Cent Second-Quarter 2009 D
  208. Pfizer Hosts Annual Meeting Of Shareholders; Declares A 16-Cent Second-Quarter 2009 D
  209. Pfizer shareholders re-elect 14 directors - Quick Facts
  210. Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
  211. Pfizer's Shareholders Approve Say-On-Pay; J&J's Say No Thanks
  212. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Ch
  213. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Ch
  214. Glaxo and Pfizer create new HIV drug company
  215. Glaxo and Pfizer create new HIV drug company
  216. Innovative partnership aims to reduce cardiovascular disease in Nova Scotia
  217. Intercytex Could Benefit From Pfizer, UCL Eye Collaboration
  218. Pfizer (NYSE:PFE) wants to treat the most common cause of blindness
  219. CIT Group, Pfizer, Microsoft, Ford big movers
  220. Pfizer pumps $75 million into state-of-the-art global headquarters for Animal Health
  221. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  222. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  223. Pfizer exec will run for Malone's seat
  224. Pfizer pumps $75 million into state-of-the-art global headquarters for Animal Health
  225. Not too enticing
  226. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  227. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  228. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  229. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  230. Pfizer Supports The Global Fight Against Malaria And Commemorates World Malaria Day –
  231. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  232. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  233. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  234. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  235. Earnings preview: Will Pfizer beat in Q1?
  236. EARNINGS OUTLOOK Pfizer, Bristol-Myers to report earnings Tuesday
  237. EARNINGS OUTLOOK Pfizer, Bristol-Myers to report earnings Tuesday
  238. Earnings preview: Will Pfizer beat in Q1?
  239. Pfizer Says Goodman Resigns as Head of Biotech Center
  240. Stocks face stress tests, Fed meet as Exxon, Pfizer due to post results
  241. Pfizer Q1 profit declines - Quick Facts
  242. SmarTrend® Opening Bell Comments -- April 28, 2009
  243. Pfizer Reports Mixed Results, Affirms Guidance
  244. Pfizer First-quarter Profit Edged Down 2%
  245. Pfizer Inc Pfizer Reports First-Quarter 2009 -6-
  246. Opening View: Flu and Banks Force Stock Futures Sharply Lower
  247. Pfizer First-quarter Profit Edged Down 2%
  248. Stocks Could See Some Further Downside In Early Trading - US Commentary
  249. Stocks Could See Some Further Downside In Early Trading - US Commentary
  250. US Stocks Poised For Weak Start, Pfizer In Focus